Abstracts Archive - Page 1782 of 2607 - ACR Meeting Abstracts

Abstract Number: 2749 • 2016 ACR/ARHP Annual Meeting
Characteristics of Ankylosing Spondylitis Patients with Primary and Secondary Lack of Efficacy to TNF-Inhibitor Treatments
Mansour Alazmi¹, Ismail Sari¹, Renise Ayearst², Nigil Haroon¹ and Robert D Inman¹, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, ²Medicine, University Health Network, Toronto, ON, Canada
Background/Purpose: Anti-TNFi agents are effective in the treatment of active AS. Based on the available data, nearly 20% of the AS patients needed to switch…
Abstract Number: 2750 • 2016 ACR/ARHP Annual Meeting
Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis
Josefina Gallino Yanzi¹, Osvaldo Luis Cerda², Margarita Landi², Cecilia Zaffarana², Emilce Schneeberger² and Gustavo Citera¹, ¹Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: In Rheumatoid Arthritis it has been observed a significant discrepancy in the global assessment of the disease by the patient and physician and this…
Abstract Number: 2751 • 2016 ACR/ARHP Annual Meeting
Gender and Disease Duration Are Associated with Extra-Articular Manifestations in Axial Spondyloarthropathy
Gillian Fitzgerald¹, Phil Gallagher², Oliver FitzGerald³, Killian O Rourke⁴, Claire Sheehy⁵, Catherine Sullivan⁶, Carmel Silke⁷, Frances Stafford⁸, Muhammad Haroon⁹, Ronan Mullan¹⁰ and Finbar O' Shea¹¹, ¹Rheumatology, St James's Hospital, Dublin 8, Ireland, ²St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, ³St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, ⁴Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland, ⁵Rheumatology, University Hospital Waterford, Waterford, Ireland, ⁶Department of Rheumatology, Cork University Hospital, Cork, Ireland, ⁷Rheumatology, Sligo University Hospital, Sligo, Ireland, ⁸Rheumatology, Blackrock Clinic, Co Dublin, Ireland, ⁹Rheumatology, Kerry General Hospital, Co Kerry, Ireland, ¹⁰Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, ¹¹Rheumatology, St. James’s Hospital, Dublin, Ireland, Dublin 8, Ireland
Background/Purpose: The Ankylosing Spondylitis Registry of Ireland (ASRI) was established in 2013. The objectives of ASRI are to provide descriptive epidemiological data on the axial…
Abstract Number: 2752 • 2016 ACR/ARHP Annual Meeting
Depression Is Associated with Worse Outcomes in Axial Spondyloarthropathy Population
Gillian Fitzgerald^1,2, Phil Gallagher³, Oliver FitzGerald⁴, Killian O Rourke⁵, Claire Sheehy⁶, Catherine Sullivan⁷, Carmel Silke⁸, Frances Stafford⁹, Muhammad Haroon¹⁰, Ronan Mullan² and Finbar O' Shea¹¹, ¹Rheumatology, St James's Hospital, Dublin 8, Ireland, ²Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, ³St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, ⁴St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, ⁵Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland, ⁶Rheumatology, University Hospital Waterford, Waterford, Ireland, ⁷Department of Rheumatology, Cork University Hospital, Cork, Ireland, ⁸Rheumatology, Sligo University Hospital, Sligo, Ireland, ⁹Rheumatology, Blackrock Clinic, Co Dublin, Ireland, ¹⁰Rheumatology, Kerry General Hospital, Co Kerry, Ireland, ¹¹Rheumatology, St. James’s Hospital, Dublin, Ireland, Dublin 8, Ireland
Background/Purpose: The association of depression with poor health outcomes in rheumatic diseases such as rheumatoid arthritis is well established. However, the impact of depression on…
Abstract Number: 2753 • 2016 ACR/ARHP Annual Meeting
Characteristic and Outcomes of Psoriatic Arthritis Patients with Hyperuricemia, Whether We Should Treat or Not?
Roaa ALJohani¹, Arik Polachek², Suzanne Li³, Vinod Chandran⁴ and Dafna D Gladman⁵, ¹Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Rheumatology, University of Toronto, Toronto, ON, Canada, ⁵University of Toronto, Toronto, ON, Canada
Background/Purpose: To determine the characteristics of psoriatic arthritis patients(PsA) with hyperuricemia(HUC)and their outcomes especially cardiovascular(CVS) and kidney diseases. Methods: Patients have been followed prospectively at…
Abstract Number: 2754 • 2016 ACR/ARHP Annual Meeting
Self-Reported Physical Activity Questionnaire in Axial Spondyloarthritis: Modification of the Squash
Fiona Maas¹, Anna Jetske Baron^1,2, Freke Wink³, Reinhard Bos³, Yvo Kamsma², Hendrika Bootsma⁴, Suzanne Arends^1,3 and Anneke Spoorenberg^1,3, ¹Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ²Center for Human Movement Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ³Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands, ⁴Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands
Background/Purpose: Improvement of physical function and physical activity are important goals in the management of axial spondyloarthritis (axSpA). Although physical function is included in the…
Abstract Number: 2755 • 2016 ACR/ARHP Annual Meeting
Comparison of Clinical Profile of Geriatric and Non-Geriatric Ankylosing Spondylitis (AS) Patients
Ahmed Omar¹, Laura Passalent², Renise Ayearst³, Ismail Sari¹, Anthony V. Perruccio⁴, Rajiv Gandhi⁵, Nigil Haroon¹ and Robert D Inman¹, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, ²Allied Health, Toronto Western Hospital, Toronto, ON, Canada, ³Medicine, University Health Network, Toronto, ON, Canada, ⁴Health Care & Outcomes Research, Krembil Research Institute, University Health Network, Toronto, ON, Canada, ⁵Department of Surgery - Orthopedics, Toronto Western Hospital, Assistant Professor, Department of Surgery, University of Toronto, Toronto, ON, Canada
Background/Purpose: Data on disease characteristics of geriatric patients (>=65 years) with AS are lacking. The objective of this study is to compare: 1) the clinical…
Abstract Number: 2756 • 2016 ACR/ARHP Annual Meeting
Gender Differences in Body Composition with Dual-Energy X-Ray Absorptiometry in TNF-α Blocker Naive Ankylosing Spondylitis Patients
Sebastián Ibáñez^1,2, Ingrid M. Visman³, Christiaan van Denderen³, Willem F. Lems^4,5, M. Nurmohamed^4,6 and Irene van der Horst - Bruinsma⁴, ¹Reumatología, Clínica Alemana de Santiago, Santiago, Chile, ²Reumatología, Hospital Padre Hurtado, Santiago, Chile, ³Rheumatology, Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands, ⁴Rheumatology, Amsterdam Rheumatology and immunology Center, VU University medical center, Amsterdam, Netherlands, ⁵Rheumatology, Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, New Caledonia, ⁶Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands
Background/Purpose: Data on body composition (BC) in Ankylosing Spondylitis (AS) are sparse and controversial. Female AS patients have less response to TNF-α blockers and a…
Abstract Number: 2757 • 2016 ACR/ARHP Annual Meeting
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
Iain B McInnes¹, Philip J Mease², Christopher T. Ritchlin³, Proton Rahman⁴, Alice B Gottlieb⁵, Bruce Kirkham⁶, Radhika Kajekar⁷, Evie Maria Delicha⁸, Luminita Pricop⁹ and Shephard Mpofu⁸, ¹University of Glasgow, Glasgow, Great Britain, ²Swedish Medical Center and University of Washington, Seattle, WA, ³Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY, ⁴Rheumatology, St Claires Mercy Hospital, St Johns, NF, Canada, ⁵Tufts University School of Medicine, Boston, MA, ⁶Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, ⁷One Health Plaza, Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁸Novartis Pharma AG, Basel, Switzerland, ⁹Novartis Pharmaceuticals Corporation, East Hanover, NJ
Background/Purpose: Secukinumab, a fully human anti–IL-17A monoclonal antibody, significantly improved signs and symptoms of psoriatic arthritis (PsA) over 52 weeks (wks) in FUTURE 2 study (NCT01752634).1,2 Here…
Abstract Number: 2758 • 2016 ACR/ARHP Annual Meeting
Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Which Unmet Criteria Are More Prevalent Among Responders?
J. Antonio Avina-Zubieta¹, Andrew Chow², Philip Baer³, John Kelsall⁴, Proton Rahman⁵, Jacqueline Stewart⁶, Boulos Haraoui⁷, Michel Zummer⁸, Emmanouil Rampakakis⁹, Eliofotisti Psaradellis¹⁰, Francois Nantel¹¹, Karina Maslova¹², Cathy Tkaczyk¹³, Brendan Osborne¹³ and Allen J Lehman¹², ¹Arthritis Research Canada, Richmond, BC, Canada, ²Credit Valley Rheumatology, Mississauga, ON, Canada, ³Independent Rheumatology Practice, Scarborough, ON, Canada, ⁴Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology, St Claires Mercy Hospital, St Johns, NF, Canada, ⁶Penticton Regional Hospital, Penticton, BC, Canada, ⁷University of Montreal, Montreal, QC, Canada, ⁸Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ⁹JSS Medical Research, St-Laurent, QC, Canada, ¹⁰JSS Medical Research, Montreal, QC, Canada, ¹¹19 Green belt Dr, Janssen Inc., Toronto, ON, Canada, ¹²Janssen Inc., Toronto, ON, Canada, ¹³Medical Affairs, Janssen Inc., Toronto, ON, Canada
Background/Purpose: Minimal disease activity (MDA) is now considered an objective target which is more attainable in psoriatic arthritis (PsA) compared to remission (DAS28 <2.6) which…
Abstract Number: 2759 • 2016 ACR/ARHP Annual Meeting
Prevalence of Comorbidities and Risk Factors of Spondyloarthritis in Latin America: A Comparative Study with the General Population: Data from the Multinational ASAS-Comospa Study
WILSON BAUTISTA-MOLANO^1,2, Robert Landewé³, Anna Molto⁴, Rubén Burgos-Vargas⁵, José Antonio Maldonado-Cocco⁶, Rafael Valle-Oñate⁷ and Désirée van der Heijde⁸, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology Department, School of Medicine, UMNG / HMC, Bogotá, Colombia, ³Amsterdam Medical Center, Amsterdam, Netherlands, ⁴Hopital Cochin, Paris Descartes University, Paris, France, ⁵Rheumatology, Hospital General de Mexico, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, ⁶Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁷Rheumatology Department, School of Medicine, UMNG / HMC, Bogota, Colombia, ⁸Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Increased risk of several comorbidities has been reported in spondyloarthritis (SpA). Data and knowledge regarding the prevalence of these comorbidities and risk factors in…
Abstract Number: 2760 • 2016 ACR/ARHP Annual Meeting
Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil
Sonia Lima¹, Rita Menin², Rejane Vieira³, Antonio Ximenes⁴, Valderilio Azevedo⁵, Claudia Suzuki⁶ and Flavia Heringer⁶, ¹Faculdade de Medicina do ABC, São Paulo, Brazil, ²AV. JUSCELINO K. DE OLIVEIRA,, Famerp, Sao Jose Rio Preto, Brazil, ³Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁴CIP- Centro Internacional de Pesquisa, Goiânia, Brazil, ⁵Federal University of Parana and Edumed Health Research Centerand Biotech, Curitiba, Brazil, ⁶AbbVie Farmacêutica Ltda., São Paulo, Brazil
Background/Purpose: This was an observational study with retrospective (phase 1) and one-month prospective (phase 2) data collection. Medical records of subjects 18-60 years old, with…
Abstract Number: 2761 • 2016 ACR/ARHP Annual Meeting
Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors
Ian Tin Yue Wong¹, Vinod Chandran², Suzanne Li³ and Dafna D Gladman⁴, ¹Faculty of Medicine, University of British Columbia, Vancouver,, BC, Canada, ²Medicine, Krembil Research Institute, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada
Background/Purpose: Psoriasis is a chronic inflammatory skin disease characterized by scaling, erythematous plaques. Up to 30% of psoriasis patients develop an inflammatory arthritis termed psoriatic…
Abstract Number: 2762 • 2016 ACR/ARHP Annual Meeting
Smoking and Severity of Psoriatic Arthritis
Sahithi Jarugula¹, Bonita Libman², Amanda Kennedy³ and Diantha Howard⁴, ¹Internal Medicine, Sahithi Jarugula, S.Burlington, VT, ²Internal Medicine, University of Vermont Medical Center, Burlington, VT, ³Internal Medicine, University of Vermont Medical center, Burlington, VT, ⁴Statistics, University of Vermont, Burlington, VT
Background/Purpose: Smoking is a major modifiable risk factor for various inflammatory diseases including rheumatoid arthritis 1, 2 and psoriasis 3,4,5. The presence of cyclic citrullinated…
Abstract Number: 2763 • 2016 ACR/ARHP Annual Meeting
New Treatment Option for SAPHO?
Jan Leipe¹, Dorothee Hauler², Johanna Meier¹, Matthias Witt¹, Mathias Grunke¹, Claudia Dechant³ and Hendrik Schulze-Koops¹, ¹Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, ²Division of Rheumatology and Clinical Immunology, University of Munich, munich, Germany, ³Division of Rheumatology and Clinical Immunology, Med. Klinik und Poliklinik IV, University of Munich, Munich, Germany
Background/Purpose: The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is a rare autoimmune disease characterized by inflammatory osteoarticular and cutaneous manifestations. Despite improvements in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].